Utah Medical Products, Inc.
US ˙ NasdaqGS ˙ US9174881089

SecurityUTMD / Utah Medical Products, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership5,805 shares
Latest Disclosed Value $ 330,420
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 0.35% increase in ownership of UTMD / Utah Medical Products, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 5,805 shares of Utah Medical Products, Inc. (US:UTMD) valued at $330,421 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 5,785 shares of Utah Medical Products, Inc.. This represents a change in shares of 0.35% during the quarter. The current value of the position is $392,708 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Utah Medical Products EC US9174881089 5,805 20 0.35 330 1.85 0.0074
2025-05-28 2025-03-31 NP Utah Medical Products EC US9174881089 5,785 0 0.00 324 -8.73 0.0078
2025-02-25 2024-12-31 NP Utah Medical Products EC US9174881089 5,785 -812 -12.31 356 -19.50 0.0078
2024-11-26 2024-09-30 NP Utah Medical Products EC US9174881089 6,597 0 0.00 441 0.23 0.0083
2024-08-26 2024-06-30 NP Utah Medical Products EC US9174881089 6,597 706 11.98 441 5.26 0.0090
2024-05-28 2024-03-31 NP Utah Medical Products EC US9174881089 5,891 -579 -8.95 419 -23.16 0.0087
2024-02-26 2023-12-31 NP Utah Medical Products EC US9174881089 6,470 482 8.05 545 5.84 0.0116
2023-11-28 2023-09-30 NP Utah Medical Products EC US9174881089 5,988 -27 -0.45 515 -8.21 0.0134
2023-08-25 2023-06-30 NP Utah Medical Products EC US9174881089 6,015 408 7.28 561 5.46 0.0133
2023-05-26 2023-03-31 NP Utah Medical Products EC US9174881089 5,607 0 0.00 531 -5.68 0.0141
2023-02-24 2022-12-31 NP Utah Medical Products EC US9174881089 5,607 0 0.00 564 17.78 0.0155
2022-11-25 2022-09-30 NP Utah Medical Products EC US9174881089 5,607 0 0.00 478 -0.62 0.0137
2022-08-25 2022-06-30 NP Utah Medical Products EC US9174881089 5,607 0 0.00 482 -4.37 0.0133
2022-05-26 2022-03-31 NP Utah Medical Products EC US9174881089 5,607 0 0.00 504 -10.18 0.0117
2022-02-25 2021-12-31 NP Utah Medical Products EC US9174881089 5,607 0 0.00 561 7.69 0.0122
2021-11-24 2021-09-30 NP Utah Medical Products EC US9174881089 5,607 0 0.00 521 9.24 0.0115
2021-08-26 2021-06-30 NP Utah Medical Products EC US9174881089 5,607 0 0.00 477 -1.86 0.0102
2021-05-27 2021-03-31 NP Utah Medical Products EC US9174881089 5,607 0 0.00 486 2.75 0.0110
2021-02-25 2020-12-31 NP Utah Medical Products EC US9174881089 5,607 0 0.00 473 5.59 0.0121
2020-11-25 2020-09-30 NP Utah Medical Products EC US9174881089 5,607 0 0.00 448 -9.88 0.0144
2020-08-27 2020-06-30 NP Utah Medical Products EC US9174881089 5,607 0 0.00 497 -5.88 0.0162
2020-06-01 2020-03-31 NP Utah Medical Products EC US9174881089 5,607 260 4.86 527 -8.51 0.0216
2020-02-27 2019-12-31 NP Utah Medical Products EC 917488108 5,347 176 3.40 577 16.36 0.0173
2019-11-27 2019-09-30 NP Utah Medical Products EC US9174881089 5,171 5,171 496 0.0164
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.